As a follow up to the 2012 DiabetesMine Innovation Summit event held last November at Stanford University, we wanted to share the gist of the keynote talk about why the development of standards for diabetes devices and data is so crucial.
We had thought to create a white paper on the topic, but on the recommendation of the wonderful Kelly Close of Close Concerns, decided that a video version would be much more impactful; it’s…
Read more »
By
AmyT on
December 26, 2012
Well, we all made through another year!
Surprised we got through this one? Especially with that purported Mayan prediction about the world ending on Dec. 21, 2012? Well, we’re still here! Predictions of doom were apparently exaggerated… Perhaps the premonitions were of something “magical” that was supposed to happen, so we were crossing our fingers for a cure being discovered or the FDA approving the best-ever fantasy diabetes device… or somesuch.
But short of that…
Read more »
By
AmyT on
December 11, 2012
Ever look at a diabetes product and wonder what the heck the developers were THINKING? People have to live with this stuff, after all! It’s even more interesting when they occasionally get it right…
Kim Blickenstaff, CEO of Tandem Diabetes Care, was unable to attend our DiabetesMine Innovation Summit event this year, but reached out to me to offer an inside view of how Tandem “got its groove on” to create the t:slim, the first-ever…
Read more »
By
AmyT on
December 5, 2012
Wow! We’re excited to welcome not one, but three senior FDA officers as joint guest posters here at the ‘Mine today. All three of these individuals attended and participated in the recent 2012 DiabetesMine Innovation Summit, which we hosted at Stanford University on Nov. 16.
Dr. Alberto Gutierrez gave an opening talk titled “How Different Constituencies Can Work Together to Improve Technology Tools for Diabetes Care” (slides here); Stayce Beck participated in our “Data and…
Read more »
By
AmyT on
November 28, 2012
To my mind, the DiabetesMine Innovation Summit I’ve hosted the last two years is not a “conference.” Rather, in the true tradition of a “Summit,” it aims to bring key decision-makers and other folks passionate about diabetes care together in one room for some very frank conversations about where we are now, what needs improvement, and how we can get to a better place as quickly as possible.
On that note, the Pharma executives and…
Read more »
